PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo. - Peng, Haisheng; Chai, Yanqun; Gong, Chen; Hao, Yue; Peng, Yanbo; Zhang, Wenyuan; Liu, Xiaoying; Tang, Shukun; Kong, Qingfei; Wang, Qun (Bioengineering & Translational Medicine, 2026)